T. Rowe Price Associates
BRLI

T. Rowe Price Associates’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

T. Rowe Price Associates’s Portfolio BRLI Stock Details BRLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-54,000
Closed -$1.63M – 2589
2014
Q2 		$1.63M Sell
54,000
-59,700
-53% -$1.65M ﹤0.01% 1617
2014
Q1 		$3.15M Sell
113,700
-16,800
-13% -$440K ﹤0.01% 1488
2013
Q4 		$3.33M Hold
130,500
– – ﹤0.01% 1472
2013
Q3 		$3.9M Sell
130,500
-6,000
-4% -$167K ﹤0.01% 1463
2013
Q2 		$3.92M Buy
+136,500
New +$3.76M ﹤0.01% 1446

Other funds holding BRLI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
MRM
Michael R. Murphy $255M AUM 0.87% 1-Year Est. Return
Tiger Global Management
Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

T. Rowe Price Associates's BRLI Position: Q3 2014 in Review

T. Rowe Price Associates sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2014, closing a stake of 54,000 shares — an estimated $1.63M sold.

T. Rowe Price Associates first reported a position in BRLI in Q2 2013 and held it in 5 quarters. The position peaked at $3.92M in Q2 2013. 168 funds tracked by Wall St. Rank hold BRLI as of Q3 2014.

  • T. Rowe Price Associates reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2014 after selling out during the quarter.
  • T. Rowe Price Associates sold 54,000 BIO-REFERENCE LABS INC-NEW- shares in Q3 2014, an estimated $1.63M.
  • T. Rowe Price Associates first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2013 and held it in 5 quarters.
  • T. Rowe Price Associates's BIO-REFERENCE LABS INC-NEW- position peaked at $3.92M in Q2 2013.
  • 168 funds tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2014.

Based on T. Rowe Price Associates's 13F filing for Q3 2014, filed 14 Nov 2014.